mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

作者: N. Li , B. Lee , R.-J. Liu , M. Banasr , J. M. Dwyer

DOI: 10.1126/SCIENCE.1190287

关键词: HydroxynorketamineBiologyEsketamineEndocrinologyRapastinelNMDA receptorSynaptic signalingSynaptogenesisNeuroscienceInternal medicineKetaminePI3K/AKT/mTOR pathway

摘要: The rapid antidepressant response after ketamine administration in treatment-resistant depressed patients suggests a possible new approach for treating mood disorders compared to the weeks or months required standard medications. However, mechanisms underlying this action of [a glutamate N-methyl-D-aspartic acid (NMDA) receptor antagonist] have not been identified. We observed that rapidly activated mammalian target rapamycin (mTOR) pathway, leading increased synaptic signaling proteins and number function spine synapses prefrontal cortex rats. Moreover, blockade mTOR completely blocked induction synaptogenesis behavioral responses models depression. Our results demonstrate these effects are opposite deficits result from exposure stress could contribute fast actions ketamine.

参考文章(14)
Nuri B. Farber, John W. Newcomer, John W. Olney, The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease. Progress in Brain Research. ,vol. 116, pp. 421- 437 ,(1998) , 10.1016/S0079-6123(08)60453-7
Robert M Berman, Angela Cappiello, Amit Anand, Dan A Oren, George R Heninger, Dennis S Charney, John H Krystal, Antidepressant effects of ketamine in depressed patients Biological Psychiatry. ,vol. 47, pp. 351- 354 ,(2000) , 10.1016/S0006-3223(99)00230-9
Sungho Maeng, Carlos A. Zarate, Jing Du, Robert J. Schloesser, Joseph McCammon, Guang Chen, Husseini K. Manji, Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors Biological Psychiatry. ,vol. 63, pp. 349- 352 ,(2008) , 10.1016/J.BIOPSYCH.2007.05.028
Yoshihiro Yoshihara, Mathias De Roo, Dominique Muller, Dendritic spine formation and stabilization Current Opinion in Neurobiology. ,vol. 19, pp. 146- 153 ,(2009) , 10.1016/J.CONB.2009.05.013
Sheldon H. Preskorn, Bryan Baker, Sheela Kolluri, Frank S. Menniti, Michael Krams, Jaren W. Landen, An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder Journal of Clinical Psychopharmacology. ,vol. 28, pp. 631- 637 ,(2008) , 10.1097/JCP.0B013E31818A6CEA
Grazyna Rajkowska, José J Miguel-Hidalgo, Jinrong Wei, Ginny Dilley, Stephen D Pittman, Herbert Y Meltzer, James C Overholser, Bryan L Roth, Craig A Stockmeier, Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression Biological Psychiatry. ,vol. 45, pp. 1085- 1098 ,(1999) , 10.1016/S0006-3223(99)00041-4
R.-J. Liu, G. K. Aghajanian, Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 105, pp. 359- 364 ,(2008) , 10.1073/PNAS.0706679105
Charles A. Hoeffer, Eric Klann, mTOR signaling: at the crossroads of plasticity, memory and disease. Trends in Neurosciences. ,vol. 33, pp. 67- 75 ,(2010) , 10.1016/J.TINS.2009.11.003
Carlos A. Zarate, Jaskaran B. Singh, Paul J. Carlson, Nancy E. Brutsche, Rezvan Ameli, David A. Luckenbaugh, Dennis S. Charney, Husseini K. Manji, A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry. ,vol. 63, pp. 856- 864 ,(2006) , 10.1001/ARCHPSYC.63.8.856